Johnson & Johnson’s stock continues to falter as the company begins defending itself at trial against a lawsuit by the state of Oklahoma, which alleges the company made billions in profits while contributing to the opioid deaths of more than 4,000 state residents over the last decade. It’s the first…
The U.S. Food and Drug Administration this week issued an order to immediately halt the sale and distribution of pelvic mesh product for treatment of pelvic organ prolapse. Boston Scientific and Coloplast are the only two companies in the U.S. still selling mesh to treat pelvic prolapse. The FDA order…
In a landmark decision the Connecticut Supreme Court this week reinstated a lawsuit filed by Sandy Hook school-shooting victims against Remington, one of the nation’s largest gun manufacturers. Families of nine victims and one survivor of the Newton, Connecticut school shooting sued Remington Outdoor Co. Inc. and other defendants, including…
The increasing number of dangerous, defective and deadly products being marketed to the American consumer continues to have a significant impact on our health and welfare. Property casualty insurance advisors continue to add exclusions even as they push corporations to increase coverage for product liability, noting adequate product liability insurance…
Prescription opioids have become the most dangerous drugs in America. A growing body of evidence suggest the prescription drug epidemic was not an unforeseen health crisis in America, but rather a carefully orchestrated push for sales and profits by some of the nation’s largest drugmakers and pharmacies, which is now…
When it comes to health care in the United States, it’s consumer beware. A look at medical device and pharmaceutical drug recalls issued by the U.S. Food & Drug Administration in 2018 illustrates the consequences of a lax regulatory and approval process run largely by the drug companies and medical…
Several blood-pressure medications containing Valsartan are being recalled. The recent announcements are the latest in a rash of dangerous and defective drugs and medical products to be recalled in 2018. Pharmacy Times reports Teva Pharmaceuticals has issued a voluntary recall in the United States of all lots of amlodipine/valsartan tablets…
Lawyers for Civil Justice reported this month that nearly half of all cases pending before federal district court judges involve Multidistrict Litigation (MDLs) — more than 124,000 cases at the end of 2017. About 90 percent of MDL cases involve product liability claims, which means, according to the study, that…
Recent drug recalls of numerous common heart medications illustrate the growing risks faced by American consumers. CNN reports the FDA has found another impurity in valsartan, Torrent Pharmaceuticals’ recalled heart drug. The generic ingredient is found in several pills that have been under voluntary recall since July. The U.S. Food and Drug…
This month’s $289 million jury award in a product- liability lawsuit against Monsanto is a historic and important victory for consumers that will likely have a watershed impact on billions of similar claims pending across the nation. In this case, plaintiff was awarded $39 million in compensatory damages and $250 million…